More conditions included in the New Medicine Service
Thirteen conditions were added to the New Medicine Service (NMS) in the CPCF from September 2021 in a move that was broadly welcomed across the sector:
- Acute coronary syndrome (ACS)
- Atrial fibrillation (AF)
- Coronary heart disease
- Epilepsy
- Glaucoma
- Gout
- Heart failure
- Hypercholesterolaemia
- Long-term risks of venous thromboembolism/embolism
- Osteoporosis
- Parkinson’s disease
- Stroke/transient ischaemic attack
- Urinary incontinence and retention.
The directions for the NMS now permit contractors who have received an exemption from the requirement to have a consultation room (due to their premises size) to provide the service remotely or at a patient’s home. All other contractors providing the service can similarly continue to provide the service remotely, where appropriate, and in the patient’s home.